← Back
Data updated: Mar 29, 2026
QUAGEN
MetabolicGastroenterologyCardiovascular
Specialty
QUAGEN is a specialty pharmaceutical company focused on Metabolic, Gastroenterology, Cardiovascular.
1942
Since
40
Drugs
-
Trials
517
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Metabolic 22%
2 drugs
Gastroenterology 22%
2 drugs
Cardiovascular 22%
2 drugs
Infectious Disease 22%
2 drugs
Immunology 11%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Merck big-pharma
Infectious Disease, Cardiovascular, Immunology, Metabolic
Johnson & Johnson big-pharma
Immunology, Infectious Disease, Cardiovascular, Metabolic
Pfizer big-pharma
Infectious Disease, Immunology, Gastroenterology
Sanofi big-pharma
Metabolic, Infectious Disease, Immunology
B BRAUN specialty
Infectious Disease, Metabolic, Cardiovascular
Active (19)
ARIPIPRAZOLE RITONAVIR LEVETIRACETAM SERTRALINE HYDROCHLORIDE MESALAMINE FLUVOXAMINE MALEATE URSODIOL ESTRADIOL MEXILETINE HYDROCHLORIDE ALBUTEROL SULFATE CLINDAMYCIN PHOSPHATE BENZTROPINE MESYLATE BUTALBITAL, ACETAMINOPHEN AND CAFFEINE BUTALBITAL AND ACETAMINOPHEN METHYLPHENIDATE HYDROCHLORIDE FLUOCINONIDE HYDROCHLOROTHIAZIDE UREX PROPYLTHIOURACIL
Discontinued (20)
GLYCOPYRROLATE LIDOCAINE OXYCODONE HYDROCHLORIDE PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE POTASSIUM CHLORIDE DEMEROL CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY CLOBETASOL PROPIONATE TRIAMCINOLONE ACETONIDE FLUOCINOLONE ACETONIDE SELEGILINE HYDROCHLORIDE REPAGLINIDE PROMETHAZINE HYDROCHLORIDE GLIMEPIRIDE VALPROIC ACID CYPROHEPTADINE HYDROCHLORIDE COLYTE-FLAVORED COLYTE COLYTE WITH FLAVOR PACKS ELDEPRYL
Company Info
- First Approval
- 1942-11-10
- Latest
- 2025-12-22
- Applications
- 46